Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
NanoString Technologies history
NanoString Technologies company history timeline
The company was founded in 2003 with an exclusive license to develop and market the technology.
In 2004, NanoString raised its first significant funding in a $4.3M series A financing.
In 2008, NanoString launched its first commercial instrument system and began international sales operations with its first multiplexed assays for gene expression analysis.
As of June 2010, the company was not yet profitable.
In 2010, the company launched new applications for the system to support microRNA analysis and copy number variation detection.
Brad Gray, a former Genzyme executive, was hired as president and CEO in 2010.
As of 2011, NanoString Technologies had raised nearly $70M with their series D.
As of July, 2012, NanoString began indicating a move towards becoming a public company by hiring several senior staff with public company experience.
In 2013, the company's IPO raised funding that was used to expand NanoString sales and marketing.
In 2019, the company launched the GeoMx™ Digital Spatial Profiler enabling highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections.
Rate NanoString Technologies' efforts to communicate its history to employees.
NanoString Technologies jobs
Do you work at NanoString Technologies?
Is NanoString Technologies' vision a big part of strategic planning?
NanoString Technologies competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Seagen | 1997 | $2.0B | 900 | - |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 615 |
| Regeneron | 1988 | $14.2B | 9,123 | 348 |
| Sanofi Genzyme | 1981 | $4.6B | 12,000 | - |
| ZymoGenetics | 1981 | $27.0M | 200 | - |
| Merck | 1891 | $64.2B | 74,000 | 1,464 |
| Vertex Pharmaceuticals | 1989 | $11.0B | 3,400 | 165 |
| Cubist Pharmaceuticals | 1992 | $926.4M | 873 | - |
| Quidel | 1979 | $1.7B | 1,500 | - |
| Medivation | 2003 | $1.0B | 628 | - |
NanoString Technologies history FAQs
Zippia gives an in-depth look into the details of NanoString Technologies, including salaries, political affiliations, employee data, and more, in order to inform job seekers about NanoString Technologies. The employee data is based on information from people who have self-reported their past or current employments at NanoString Technologies. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by NanoString Technologies. The data presented on this page does not represent the view of NanoString Technologies and its employees or that of Zippia.
NanoString Technologies may also be known as or be related to NANOSTRING TECHNOLOGIES INC, NanoString Technologies, NanoString Technologies Inc, NanoString Technologies, Inc. and Nanostring Technologies, Inc.